Health Care & Life Sciences » Pharmaceuticals | Reyon Pharmaceutical Co. Ltd.

Reyon Pharmaceutical Co. Ltd.

Reyon Pharmaceutical Co. Ltd.
Stock Exchange Korea Exchange Commodity Market
EPS
KRW176.52
Market Cap
KRW266.93 B
Shares Outstanding
16.77 M
Public Float
5.69 M

Profile

Address
8th Floor, Cosmo Tower
Seoul SL 06176
Korea, Republic Of
Employees -
Website http://reyonpharm.co.kr
Updated 07/08/2019
REYON PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceuticla products. Its products include medicines for antibiotic, circulatory system, anti-inflammation, contrast media, and others. The Company was founded on November 25, 1984 and is headquartered in Seoul, South Korea.

Financials

View All
Created with Highcharts 5.0.14Reyon Pharmaceutical Co. Ltd.Net Income. Fiscal year is January-December. All values KRW Millions.11 29311 29311 59311 59311 33811 33811 79211 79213 42413 4241 3431 34320132014201520162017201802.5k5k7.5k10k12.5k15k
Created with Highcharts 5.0.14Reyon Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is January-December. All values KRW Millions.109 693109 693112 112112 112114 507114 507121 847121 847126 253126 253122 990122 990201320142015201620172018025k50k75k100k125k150k

Soon-Ok Jeong
Chairman & Co-Chief Executive Officer
Seok-Ho Lee
Outside Director